Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-25 @ 7:17 PM
NCT ID:
NCT03388632
Group ID:
EG004
Title:
Arm C Triplet 2-Recombinant Human Interleukin(rHIL-15) 1mcg/kg/Nivolumab 240mg/Ipilimumab 1mg/kg
Description:
Triplet, cycles 1-4: Recombinant Human Interleukin (rH IL-15) subcutaneous (SC) day(d)1-8 \& 22-29, Nivolumab intravenous (IV) d8, 22, \& 36 and Ipilimumab IV d8. TRIPLET 2: Cycle 1-4, IL-15: 1 mcg/kg subcutaneously on d1-8 \& d22-29 plus Nivolumab 240 mg IV over 60-minute (min) d8, 22, \& 36 and Ipilimumab 1 mg/kg IV over 90 min d8; Cycle 5+ Nivolumab 240 mg IV over 60 min on d1, 15 \& 29 plus Ipilimumab 1 mg/kg IV over 90 min d1.
Deaths Number Affected:
1
Deaths Number At Risk:
None
Serious Number Affected:
13
Serious Number At Risk:
18
Other Number Affected:
18
Other Number At Risk:
18
Study:
NCT03388632
Results Section:
NCT03388632
Adverse Events Module:
NCT03388632